The Medical Weight Loss Show

Peptides are everywhere—from TikTok and Instagram to online wellness companies promising fat loss, anti-aging, muscle growth, and longevity. But are they safe? And are they right for everyone?

In this episode of The Medical Weight Loss Show, Dr. Andrea Walker discusses why she doesn't prescribe every trending peptide on the market and explains the importance of medical oversight, informed consent, and individualized care.

Learn why Retatrutide, CJC-1295, Ipamorelin, BPC-157, and GHK-Cu, and others should be considered carefully before using and discover why "research use only" should never be ignored.

Your health is too important to trust to social media trends. Before you inject anything into your body, make sure you know what's in it, where it came from, and whether it's truly appropriate for you.

Because when it comes to your health, safety should always come first.

If you are currently taking a GLP-1 like Semaglutide or Tirzepatide and concerned about gaining weight after discontinuing — then this episode is for you. Gaining fat is a real issue.

In this episode of The Medical Weight Loss Show, Dr. Andrea Walker, DNP, FNP-C—owner of Serenity Health & Wellness—breaks down the growing discussion highlighted in recent media coverage about “yo-yo” weight gain after stopping GLP-1 medications.

Many patients will experience weight regain—but what’s most concerning isn’t just the number on the scale. It’s how the body regains weight, often favoring fat over muscle, and what that means for long-term metabolic health.

Dr. Walker explains:
• Why appetite and hunger hormones rebound after stopping GLP-1s
• The science behind metabolic adaptation and weight regain
• How muscle loss during weight loss impacts body composition
• Why repeated weight cycling can worsen metabolic health
• The importance of strength training, protein intake, and maintenance planning
• How to create a sustainable, long-term weight loss strategy

This episode is a must-listen for anyone currently on GLP-1 medications, considering them, or struggling to maintain weight loss.

Because real success isn’t just losing weight—it’s keeping it off.

Recent headlines mention Ozempic and 3 deaths, leaving many patients wondering if these popular weight-loss medications are actually safe.

But what did the FDA really say?

In this episode of The Medical Weight Loss Show, Nurse Practitioner and weight loss specialist Dr. Andrea Walker breaks down the facts behind the recent news reports.

You’ll learn:

• Why adverse event reports do NOT prove a medication caused a death
• The difference between association and causation in drug safety reporting
• The role of compounded semaglutide vs FDA-approved medications
• What patients taking GLP-1 medications for weight loss or diabetes should know

This episode cuts through the media headlines and misinformation to provide a clear, fact-based explanation of how medication safety reporting works and what the current evidence actually shows about GLP-1 drugs.

In this episode of The Medical Weight Loss Show, Dr. Andrea Walker addresses common fears patients have after seeing rapid weight loss stories on TikTok. She explains the truth about losing 20 pounds in one month, muscle loss, sagging skin, and even dental concerns. Learn how proper medical supervision, nutrition, and follow-up care make the difference between unhealthy rapid weight loss and safe, sustainable fat loss.

Have you ever wondered how someone can eat until they’re full—and still feel hungry all day?
In this episode, Dr. Andrea Walker breaks down why constant hunger is not a willpower issue, not a discipline problem, and not a personal failure.

We dive into the real science behind hunger, including the role of hormones like ghrelin and leptin, blood sugar instability, stress, sleep, diet culture, and metabolic adaptation. You’ll learn why fullness and hunger are not the same thing, how “food noise” develops, and why so many people feel at war with their bodies around food.

Dr. Walker also explains how GLP-1 medications fit into the bigger picture—not as a shortcut, but as a tool that helps restore normal hunger signaling—and what you can start doing today to better support your metabolism, whether or not medication is part of your journey.

If you’ve ever felt confused, frustrated, or ashamed by your hunger, this episode is for you.
Your body isn’t broken—it’s been trying to protect you.

🎧 Listen in, share with someone who needs to hear this, and give yourself grace.

In this episode of The Medical Weight Loss Show, Dr. Andrea Walker, FNP-C, DNP breaks down the latest advancement in medical weight loss—the newly approved Wegovy pill.

With so much buzz around oral GLP-1 medications, many people are asking: Does the pill work as well as injections? Is it safer? And how does it compare to compounded semaglutide or tirzepatide?

Dr. Walker explains how the Wegovy pill works, why oral dosing differs from injections, and what current research shows about its effectiveness and side effects. She also addresses the role of compounding pharmacies, FDA regulations, and why medication quality and provider-guided care matter when it comes to long-term weight loss success.

Whether you’re considering weight-loss medication or simply want to stay informed, this episode provides a clear, evidence-based perspective to help you make confident decisions about your health

GLP-1 medications have transformed medical weight loss—but not all weight loss is healthy. In this episode, Dr. Andrea Walker, FNP-C, DNP explores an often-overlooked consequence of rapid weight loss: body dysmorphia. From patients whose BMI drops into an underweight range due to GLP-1 overuse, to those who are losing weight appropriately but struggle to see their progress, this episode addresses both sides of the issue. Dr. Walker breaks down BMI categories, discusses the risks of continued medication use at low BMI, and examines how celebrity culture and social media are reshaping unhealthy body standards. A necessary conversation on ethical prescribing, mental health, and knowing when to stop.

Why do GLP-1 medications seem to work great the first time—but not as well when you stop and restart them?

In this episode of The Medical Weight Loss Show, Dr. Andrea Walker, FNP, IFBB Pro, breaks down why repeatedly going on and off GLP-1 medications can actually make weight loss harder over time. Drawing from years of clinical experience, Dr. Walker explains the science behind metabolic adaptation, hormone regulation, receptor response, and why appetite, cravings, and weight regain often feel worse after stopping.

You’ll learn:

• Why GLP-1s are difficult to manage without a long-term plan

• Why weight regain happens so quickly after stopping

• Why GLP-1 medications may take longer to work—or feel less effective—when restarted

• How muscle loss, insulin resistance, and stress impact results

• Why obesity should be treated as a chronic medical condition, not a short-term fix

This episode is educational, honest, and empowering—without judgment or shame. Whether you’re currently on a GLP-1, considering stopping, or thinking about restarting, this conversation will help you understand what your body is actually doing and how to work with it instead of against it.

In this episode of The Medical Weight Loss Show, Dr. Andrea Walker, FNP and IFBB Pro, breaks down the most common supplements added to personalized compounded GLP-1 medications. From glycine and L-carnitine to B-vitamins, NAD⁺, MIC, and now low-dose naltrexone, Dr. Walker explains what each component does, why it may be included in your formulation, and how these additions support metabolism, energy, craving control, liver function, and overall weight-loss success.

Whether you’re currently on GLP-1 therapy or considering it, this episode will help you understand how personalized dosing works and how these powerful add-ons can enhance your results.

Dr. Walker also provides a clear medical disclaimer and closes with weekly encouragement to stay consistent on your health journey.

Tune in, learn more about your medication, and finish 2025 strong!

In this episode of The Medical Weight Loss Show, Dr. Andrea Walker dives into the growing trend of microdosing compounded GLP-1 medications — and why it’s a game changer for those who don’t meet traditional BMI requirements or simply want to maintain their results.

Unlike standard GLP-1 dosing used for weight loss, microdosing focuses on longevity, anti-aging, and metabolic health. These customized compounds are often blended with ingredients like B vitamins or NAD+ to enhance energy, cellular repair, and vitality.

Dr. Walker explains how this approach supports insulin sensitivity, inflammation reduction, hormonal balance, and overall metabolic optimization — without the extreme appetite suppression or continued weight loss seen at higher doses.

Whether you’re in maintenance mode or simply interested in long-term wellness, this episode reveals how microdosing GLP-1s bridges the gap between weight management and total body health.

💚 Tune in, like, and share — and discover why microdosing is the next evolution in personalized wellness.